WallStSmart
YDES

YD Bio Ltd

NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY

$4.88
-6.06% today

Updated 2026-11-13

Market cap
$422.86M
P/E ratio
—
P/S ratio
341.21x
EPS (TTM)
$-0.05
Dividend yield
—
52W range
$2 – $16
Volume
0.3M

YD Bio Ltd (YDES) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$4.88
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 24.70%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.